| Literature DB >> 14701744 |
Elena Vigorito1, Sarah Bell, Barbara J Hebeis, Helen Reynolds, Simon McAdam, Piers C Emson, Andrew McKenzie, Martin Turner.
Abstract
RhoG is a low-molecular-weight GTPase highly expressed in lymphocytes that activates gene transcription and promotes cytoskeletal reorganization in vitro. To study the in vivo function of RhoG, we generated mice homozygous for a targeted disruption of the RhoG gene. Despite the absence of RhoG, the development of B and T lymphocytes was unaffected. However, there was an increase in the level of serum immunoglobulin G1 (IgG1) and IgG2b as well as a mild increase of the humoral immune response to thymus-dependent antigens. In addition, B- and T-cell proliferation in response to antigen receptor cross-linking was slightly increased. Although RhoG deficiency produces a mild phenotype, our experiments suggest that RhoG may contribute to the negative regulation of immune responses. The lack of a strong phenotype could indicate a functional redundancy of RhoG with other Rac proteins in lymphocytes.Entities:
Mesh:
Substances:
Year: 2004 PMID: 14701744 PMCID: PMC343784 DOI: 10.1128/MCB.24.2.719-729.2004
Source DB: PubMed Journal: Mol Cell Biol ISSN: 0270-7306 Impact factor: 4.272